304 related articles for article (PubMed ID: 30903103)
1. FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis.
Turunen SP; von Nandelstadh P; Öhman T; Gucciardo E; Seashore-Ludlow B; Martins B; Rantanen V; Li H; Höpfner K; Östling P; Varjosalo M; Lehti K
Cell Death Differ; 2019 Dec; 26(12):2577-2593. PubMed ID: 30903103
[TBL] [Abstract][Full Text] [Related]
2. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
Zhang P; Zhang H; Wang Y
Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.
Yuan Z; Kim D; Shu S; Wu J; Guo J; Xiao L; Kaneko S; Coppola D; Cheng JQ
J Biol Chem; 2010 Feb; 285(6):3815-3824. PubMed ID: 19940129
[TBL] [Abstract][Full Text] [Related]
4. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
5. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
[TBL] [Abstract][Full Text] [Related]
6. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.
Praskova M; Khoklatchev A; Ortiz-Vega S; Avruch J
Biochem J; 2004 Jul; 381(Pt 2):453-62. PubMed ID: 15109305
[TBL] [Abstract][Full Text] [Related]
8. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
[TBL] [Abstract][Full Text] [Related]
9. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation.
Praskova M; Xia F; Avruch J
Curr Biol; 2008 Mar; 18(5):311-21. PubMed ID: 18328708
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.
Tiong KH; Tan BS; Choo HL; Chung FF; Hii LW; Tan SH; Khor NT; Wong SF; See SJ; Tan YF; Rosli R; Cheong SK; Leong CO
Oncotarget; 2016 Sep; 7(36):57633-57650. PubMed ID: 27192118
[TBL] [Abstract][Full Text] [Related]
11. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo.
Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS
Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732
[TBL] [Abstract][Full Text] [Related]
12. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
[TBL] [Abstract][Full Text] [Related]
13. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
14. MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.
Zhou Y; Adolfs Y; Pijnappel WW; Fuller SJ; Van der Schors RC; Li KW; Sugden PH; Smit AB; Hergovich A; Pasterkamp RJ
Mol Cell Biol; 2011 Sep; 31(17):3603-15. PubMed ID: 21730291
[TBL] [Abstract][Full Text] [Related]
15. Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.
Kim D; Shu S; Coppola MD; Kaneko S; Yuan ZQ; Cheng JQ
PLoS One; 2010 Mar; 5(3):e9616. PubMed ID: 20231902
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer.
Zou Y; Zheng S; Xie X; Ye F; Hu X; Tian Z; Yan SM; Yang L; Kong Y; Tang Y; Tian W; Xie J; Deng X; Zeng Y; Chen ZS; Tang H; Xie X
Nat Commun; 2022 May; 13(1):2672. PubMed ID: 35562334
[TBL] [Abstract][Full Text] [Related]
17. Hippo kinases regulate cell junctions to inhibit tumor metastasis in response to oxidative stress.
Wang Y; Li J; Gao Y; Luo Y; Luo H; Wang L; Yi Y; Yuan Z; Jim Xiao ZX
Redox Biol; 2019 Sep; 26():101233. PubMed ID: 31212215
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.
Song H; Mak KK; Topol L; Yun K; Hu J; Garrett L; Chen Y; Park O; Chang J; Simpson RM; Wang CY; Gao B; Jiang J; Yang Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1431-6. PubMed ID: 20080598
[TBL] [Abstract][Full Text] [Related]
19. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
20. The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells.
Roidl A; Foo P; Wong W; Mann C; Bechtold S; Berger HJ; Streit S; Ruhe JE; Hart S; Ullrich A; Ho HK
Oncogene; 2010 Mar; 29(10):1543-52. PubMed ID: 19946327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]